Skip to Content
Merck
All Photos(3)

Key Documents

View All Documentation

Safety Information

P13002

Sigma-Aldrich

1,10-Phenanthroline monohydrochloride monohydrate

97%

Synonym(s):

1,10-Phenanthroline hydrochloride monohydrate, o-Phenanthroline hydrochloride monohydrate

Sign Into View Organizational & Contract Pricing
All Photos(3)

About This Item

Empirical Formula (Hill Notation):
C12H8N2 · HCl · H2O
CAS Number:
18851-33-7
Molecular Weight:
234.68
Beilstein:
4007967
EC Number:
223-325-1
MDL number:
MFCD00150061
UNSPSC Code:
12352100
PubChem Substance ID:
24898183
NACRES:
NA.22

Quality Level

100

Assay

97%

form

solid

mp

224-225 °C (lit.)

SMILES string

O.Cl.c1cnc2c(c1)ccc3cccnc23

InChI

1S/C12H8N2.ClH.H2O/c1-3-9-5-6-10-4-2-8-14-12(10)11(9)13-7-1;;/h1-8H;1H;1H2

InChI key

NDLHUHRGAIHALB-UHFFFAOYSA-N

Looking for similar products? Visit Product Comparison Guide

Pictograms

Skull and crossbonesEnvironment
GHS06,GHS09

Signal Word

Danger

Hazard Statements

H301,H410

Hazard Classifications

Acute Tox. 3 Oral - Aquatic Acute 1 - Aquatic Chronic 1

Storage Class Code

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Personal Protective Equipment

dust mask type N95 (US), Eyeshields, Gloves

Regulatory Listings

Regulatory Listings are mainly provided for chemical products. Only limited information can be provided here for non-chemical products. No entry means none of the components are listed. It is the user’s obligation to ensure the safe and legal use of the product.

JAN Code

P13002-10G:
P13002-BULK:
P13002-25G:
P13002-VAR:

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
STBK8565
STBK6349
STBK2849
STBK2206
STBJ9996

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

T M-H Nguyen et al.
International journal of pharmaceutics, 482(1-2), 21-26 (2014-12-03)
Hyperphosphatemia is one of the main risk factors contributing to morbidity and mortality in patients with end stage renal disease. The demand for a new phosphate binder is continuously increasing since the number of patients suffering under hyperphosphatemia is growing.

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service